Dextenza intraocular and Recombinate recombinant
Determining the interaction of Dextenza intraocular and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza intraocular-Recombivax
- Dextenza intraocular-Recombivax HB
- Dextenza intraocular-Recombivax HB Adult
- Dextenza intraocular-Recombivax HB Dialysis Formulation
- Dextenza intraocular-Recombivax HB Pediatric/Adolescent
- Dextenza intraocular-Recort Plus
- Recombinate recombinant-Dextran 40
- Recombinate recombinant-Dextran 70 6% in 5% Dextrose high molecular weight
- Recombinate recombinant-Dextran 75
- Recombinate recombinant-Dextran high molecular weight
- Recombinate recombinant-Dextranomer and Hyaluronate Derivatives (Deflux)
- Recombinate recombinant-Dextranomer and Hyaluronate Derivatives (Solesta)